At a glance
- Originator Pharmacia Corporation
- Class Small molecules
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Nausea and vomiting; Psychotic disorders
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 05 Feb 1997 No-Development-Reported for Anxiety disorders in Italy (Unknown route)
- 05 Feb 1997 No-Development-Reported for Emesis in Italy (Unknown route)